OverviewSuggest Edit

Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company’s patented "Veto-Cell" technology represents a major breakthrough in immune system management - safe and selective “tolerizing” of immune response. 
Cell Source is commercializing this groundbreaking innovation. Potential applications range from facilitating bone marrow and organ transplantation to effectively treating both blood cancers (e.g., Lymphoma) and non-malignant congenital diseases (e.g., Sickle Cell Anemia).
... Show more
TypePublic
Founded2011
HQNew York, US
Websitecell-source.com

Locations

Cell Source is headquartered in
New York, United States

Location Map

Latest Updates

Employees (est.) (Feb 2019)1(-50%)

Key People/Management at Cell Source

Dennis Brown

Dennis Brown

Chairman of the Board
Herman Waldmann

Herman Waldmann

Scientific Advisory Board
Steven Burakoff

Steven Burakoff

Scientific Advisory Board
Robert Negrin

Robert Negrin

Scientific Advisory Board
Hermann Einsele

Hermann Einsele

Scientific Advisory Board
Michael Farber

Michael Farber

Strategic Patent Advisor
Show more

Cell Source Office Locations

Cell Source has an office in New York
New York, US (HQ)
400 57 W 57th St
Show all (1)
Report incorrect company information

Cell Source Financials and Metrics

Cell Source Revenue

USD

Net income (Q2, 2018)

(360.7k)

EBIT (Q2, 2018)

(423.9k)

Cash (30-Jun-2018)

2.5k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2017

General and administrative expense

1.3k2.2m1.1m815.9k

R&D expense

806.2k392.9k637.3k

Operating expense total

25.6k3.0m2.3m2.3m

EBIT

(4.1m)(2.3m)(2.3m)
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2017

Cash

18.7k19.5k6.9k371.0k

Current Assets

18.7k121.0k338.2k531.7k

PP&E

2.1k1.3k

Total Assets

123.1k367.8k531.7k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

12.5k2.2k889.3k104.1k5.9k99.1k17.7k17.6k40.2k211.1k2.5k

Current Assets

12.5k2.2k1.1m270.7k290.1k406.4k66.4k228.3k150.1k

PP&E

2.6k2.3k1.5k1.1k192.0

Total Assets

1.1m273.0k311.6k407.4k66.6k228.3k150.1k410.9k131.5k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2017

Net Income

(4.1m)(2.5m)(3.1m)

Depreciation and Amortization

455.0860.0407.0

Accounts Payable

28.5k323.9k(17.3k)

Cash From Operating Activities

(23.4k)(3.1m)(2.0m)(2.3m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(1.8m)(2.5m)(1.8m)(820.4k)(1.1m)(2.0m)(2.5m)(712.2k)(1.1m)

Depreciation and Amortization

25.0240.0645.0215.0215.0407.0407.0

Accounts Payable

(271.7k)(369.8k)305.7k(63.7k)13.5k36.5k35.3k394.061.3k

Cash From Operating Activities

(9.6k)(16.5k)(2.1m)(2.9m)(1.5m)(803.3k)(334.3k)(1.1m)(1.4m)(710.0k)(918.5k)
Show all financial metrics
Report incorrect company information

Cell Source Company Life and Culture

Report incorrect company information

Cell Source Frequently Asked Questions

  • When was Cell Source founded?

    Cell Source was founded in 2011.

  • Who are Cell Source key executives?

    Cell Source's key executives are Dennis Brown, Herman Waldmann and Steven Burakoff.

  • How many employees does Cell Source have?

    Cell Source has 1 employees.

  • Who are Cell Source competitors?

    Competitors of Cell Source include OptiScan Biomedical, Novacyt and RealBio Technology.

  • Where is Cell Source headquarters?

    Cell Source headquarters is located at 400 57 W 57th St, New York.

  • Where are Cell Source offices?

    Cell Source has an office in New York.

  • How many offices does Cell Source have?

    Cell Source has 1 office.